ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

U.S. Tobacco Program Loses $505 il. In Loan Principle, Report Finds

January 5, 1990

In Brief: ONS Lectures Announced; Brennan To Retire As Michigan Cancer Foundation President

April 19, 1991

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

October 31, 2008

Medicare Covers All PET Scans For Cancer In New Program

May 26, 2006

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

Recision, 1981 Budget Threats Hangover NCI

March 14, 1980